CKPT
Price
$4.04
Change
-$0.00 (-0.00%)
Updated
Apr 3 closing price
Capitalization
339.24M
TRVI
Price
$6.22
Change
-$0.06 (-0.96%)
Updated
Apr 3 closing price
Capitalization
600.88M
34 days until earnings call
Ad is loading...

CKPT vs TRVI

Header iconCKPT vs TRVI Comparison
Open Charts CKPT vs TRVIBanner chart's image
Checkpoint Therapeutics
Price$4.04
Change-$0.00 (-0.00%)
Volume$3.95M
Capitalization339.24M
Trevi Therapeutics
Price$6.22
Change-$0.06 (-0.96%)
Volume$1.06M
Capitalization600.88M
CKPT vs TRVI Comparison Chart
Loading...
CKPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CKPT vs. TRVI commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CKPT is a Buy and TRVI is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (CKPT: $4.04 vs. TRVI: $6.22)
Brand notoriety: CKPT and TRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CKPT: 136% vs. TRVI: 43%
Market capitalization -- CKPT: $339.24M vs. TRVI: $600.88M
CKPT [@Biotechnology] is valued at $339.24M. TRVI’s [@Biotechnology] market capitalization is $600.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CKPT’s FA Score shows that 0 FA rating(s) are green whileTRVI’s FA Score has 0 green FA rating(s).

  • CKPT’s FA Score: 0 green, 5 red.
  • TRVI’s FA Score: 0 green, 5 red.
According to our system of comparison, TRVI is a better buy in the long-term than CKPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CKPT’s TA Score shows that 3 TA indicator(s) are bullish while TRVI’s TA Score has 4 bullish TA indicator(s).

  • CKPT’s TA Score: 3 bullish, 7 bearish.
  • TRVI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TRVI is a better buy in the short-term than CKPT.

Price Growth

CKPT (@Biotechnology) experienced а +0.25% price change this week, while TRVI (@Biotechnology) price change was -4.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

CKPT is expected to report earnings on May 15, 2023.

TRVI is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRVI($601M) has a higher market cap than CKPT($339M). TRVI YTD gains are higher at: 50.971 vs. CKPT (26.250). CKPT has higher annual earnings (EBITDA): -37.51M vs. TRVI (-44.19M). TRVI has more cash in the bank: 65.5M vs. CKPT (4.7M). TRVI has less debt than CKPT: TRVI (1.11M) vs CKPT (2.47M). CKPT has higher revenues than TRVI: CKPT (47K) vs TRVI (0).
CKPTTRVICKPT / TRVI
Capitalization339M601M56%
EBITDA-37.51M-44.19M85%
Gain YTD26.25050.97151%
P/E RatioN/AN/A-
Revenue47K0-
Total Cash4.7M65.5M7%
Total Debt2.47M1.11M222%
FUNDAMENTALS RATINGS
CKPT vs TRVI: Fundamental Ratings
CKPT
TRVI
OUTLOOK RATING
1..100
2989
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
10068
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3535
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRVI's Valuation (59) in the Pharmaceuticals Major industry is somewhat better than the same rating for CKPT (93). This means that TRVI’s stock grew somewhat faster than CKPT’s over the last 12 months.

TRVI's Profit vs Risk Rating (68) in the Pharmaceuticals Major industry is in the same range as CKPT (100). This means that TRVI’s stock grew similarly to CKPT’s over the last 12 months.

TRVI's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as CKPT (100). This means that TRVI’s stock grew similarly to CKPT’s over the last 12 months.

TRVI's Price Growth Rating (35) in the Pharmaceuticals Major industry is in the same range as CKPT (35). This means that TRVI’s stock grew similarly to CKPT’s over the last 12 months.

TRVI's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as CKPT (100). This means that TRVI’s stock grew similarly to CKPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CKPTTRVI
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 17 days ago
86%
Bullish Trend 17 days ago
81%
Declines
ODDS (%)
Bearish Trend 30 days ago
86%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
CKPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PLFPX27.91N/A
N/A
Principal Large Cap S&P 500 Index R5
WLTTX10.69N/A
N/A
Wilshire International Equity Instl
CBBYX6.42N/A
N/A
AB Relative Value Advisor
RCSIX12.73N/A
N/A
RBC Small Cap Core I
CHDVX12.89-0.42
-3.16%
Cullen High Dividend Equity I

CKPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CKPT has been loosely correlated with CYCC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CKPT jumps, then CYCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CKPT
1D Price
Change %
CKPT100%
N/A
CYCC - CKPT
52%
Loosely correlated
-6.20%
PTGX - CKPT
47%
Loosely correlated
-3.53%
GPCR - CKPT
43%
Loosely correlated
-3.66%
MLYS - CKPT
42%
Loosely correlated
-3.36%
CARA - CKPT
40%
Loosely correlated
-2.94%
More

TRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRVI has been loosely correlated with PTGX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TRVI jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRVI
1D Price
Change %
TRVI100%
-0.96%
PTGX - TRVI
41%
Loosely correlated
-3.53%
CKPT - TRVI
35%
Loosely correlated
N/A
MLYS - TRVI
30%
Poorly correlated
-3.36%
QURE - TRVI
30%
Poorly correlated
-8.19%
XENE - TRVI
29%
Poorly correlated
-2.38%
More